JNJ
230.49
+2.4%↑
UNH
366.37
-0.47%↓
TMO
470.56
+0.12%↑
ISRG
450.54
-0.34%↓
ABT
90.55
-2%↓
JNJ
230.49
+2.4%↑
UNH
366.37
-0.47%↓
TMO
470.56
+0.12%↑
ISRG
450.54
-0.34%↓
ABT
90.55
-2%↓
JNJ
230.49
+2.4%↑
UNH
366.37
-0.47%↓
TMO
470.56
+0.12%↑
ISRG
450.54
-0.34%↓
ABT
90.55
-2%↓
JNJ
230.49
+2.4%↑
UNH
366.37
-0.47%↓
TMO
470.56
+0.12%↑
ISRG
450.54
-0.34%↓
ABT
90.55
-2%↓
JNJ
230.49
+2.4%↑
UNH
366.37
-0.47%↓
TMO
470.56
+0.12%↑
ISRG
450.54
-0.34%↓
ABT
90.55
-2%↓
24h
Praegune
Min
81.57
Max
84.9
Sissetulek | -557K -36M |
|---|---|
Müük | 10M 22M |
Aktsiakasum | -1.29 |
Kasumimarginaal | -165.447 |
Töötajad | 63 |
EBITDA | 10M -19M |
Soovitused | Tugev "osta" hinnang |
|---|---|
12 kuu keskmine prognoos | +65.11% upside |
Järgmine tulemuste avaldamine | 7. mai 2026 |
|---|
Turukapital | 946M 2.9B |
|---|---|
Eelmine avamishind | 81.35 |
Eelmine sulgemishind | 84.1 |
By Trading Central
Kindlus
Strong Bearish Evidence
0.5949 / 0.7406 Toetus ja vastupanu
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
29. apr 2026, 23:53 UTC
Naver Posts Weaker First-Quarter Earnings
DJ
Loe
29. apr 2026, 23:41 UTC
Stocks to Watch: Meta Platforms, Alphabet, Qualcomm, Amazon.com
DJ
Loe
29. apr 2026, 23:55 UTC
Samsung Electronics 1Q Net Profit Beat FactSet-Compiled Consensus
DJ
Loe
29. apr 2026, 23:54 UTC
Samsung Electronics 1Q Net KRW47.225T Vs. Net KRW8.223T >005930.SE
DJ
Loe
29. apr 2026, 23:52 UTC
Samsung Electronics 1Q Oper Pft KRW57.233T Vs. Pft KRW6.685T >005930.SE
DJ
Loe
29. apr 2026, 23:51 UTC
Samsung Electronics 1Q Rev KRW133.873T Vs. KRW79.141T >005930.SE
DJ
Loe
29. apr 2026, 23:51 UTC
Nikkei May Fall Amid Uncertainty Over Mideast Conflict -- Market Talk
DJ
Loe
29. apr 2026, 23:34 UTC
Gold Edges Higher on Likely Technical Recovery -- Market Talk
DJ
Loe
29. apr 2026, 23:24 UTC
CSC Financial 1Q Results Supported By Higher Income From Fees, Commission>6066.HK
DJ
Loe
29. apr 2026, 23:24 UTC
CSC Financial Gains From Changes in Fair Value on Financial Assets Also Aided Results>6066.HK
DJ
Loe
29. apr 2026, 23:24 UTC
CSC Financial 1Q Net CNY3.67B Vs. Net CNY1.84B >6066.HK
DJ
Loe
29. apr 2026, 23:24 UTC
CSC Financial 1Q Rev CNY7.70B Vs. CNY4.74B >6066.HK
DJ
Loe
29. apr 2026, 23:22 UTC
China Longyuan 1Q Net CNY1.70B, Down 14%
DJ
Loe
29. apr 2026, 23:22 UTC
China Longyuan: Power Generation Down 2.9% as of End-March
DJ
Loe
29. apr 2026, 23:20 UTC
China Longyuan: 1Q Rev From Wind Power Fell, Rev From Solar Power Rose
DJ
Loe
29. apr 2026, 23:20 UTC
China Longyuan 1Q Rev CNY7.87B, Down 3.6%
DJ
Loe
29. apr 2026, 23:19 UTC
China Vanke 1Q Loss CNY5.95B Vs. Loss CNY6.25B >000002.SZ
DJ
Loe
29. apr 2026, 23:19 UTC
China Vanke: Weak China Real Estate Market Continue to Weigh on Results>000002.SZ
DJ
Loe
29. apr 2026, 23:19 UTC
China Vanke 1Q Rev CNY28.93B Vs. CNY37.99B >000002.SZ
DJ
Loe
29. apr 2026, 23:19 UTC
China Vanke 1Q Loss Narrows>000002.SZ
DJ
Loe
29. apr 2026, 23:18 UTC
Naver1Q Net Profit Missed FactSet-Compiled Consensus
DJ
Loe
29. apr 2026, 23:17 UTC
Naver 1Q Net KRW291.00B Vs. Net KRW423.70B >035420.SE
DJ
Loe
29. apr 2026, 23:15 UTC
Naver 1Q Oper Pft KRW541.80B Vs. Pft KRW505.30B >035420.SE
DJ
Loe
29. apr 2026, 23:15 UTC
Naver 1Q Rev KRW3.241T Vs. KRW2.787T >035420.SE
DJ
Loe
29. apr 2026, 23:13 UTC
CICC: Gains From Investments in Financial Instruments Also Aided Results >3908.HK
DJ
Loe
29. apr 2026, 23:12 UTC
CICC Results Supported by Increase in Fee, Commission Income >3908.HK
DJ
Loe
29. apr 2026, 23:11 UTC
CICC 1Q Rev CNY8.83B Vs. CNY5.72B >3908.HK
DJ
Loe
29. apr 2026, 23:11 UTC
CICC 1Q Net CNY3.58B Vs. Net CNY2.04B >3908.HK
DJ
Loe
29. apr 2026, 23:04 UTC
Microsoft Reports Strong Cloud Growth, but Questions About AI Returns Persist -- WSJ
DJ
Loe
29. apr 2026, 23:04 UTC
Meta Reports Big Revenue Jump and Projected Spending Increase -- 3rd Update
DJ
Loe
Hinnamuutus
By TipRanks
12 kuu keskmine prognoos
Keskmine 138.38 USD 65.11%
Kõrge 185 USD
Madal 95 USD
Põhineb 8 Wall Streeti analüütiku instrumendi Nektar Therapeutics 12 kuu hinnasihil - viimase 3 kuu andmed.
By TipRanks
Tugev "osta" hinnang
8 ratings
7
Osta
1
Hoia
0
Müü
Põhineb 8 analüütiku instrumendi Nektar Therapeutics aktsia reitingul - viimase 3 kuu andmed.
By Trading Central
Lühikene perspektiiv
Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Keskpikk perspektiiv
Strong Bearish Evidence
All events are bearish.
Pikk perspektiiv
Bearish Evidence
All events are bearish.
Müügi- ja halduskulud
Tegevuskulud
Maksueelne kasum
Müük
Müügikulu
Brutokasum müügist
Intressikulud võla pealt
EBITDA
Ärikasum
$